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| BACKGROUND
Pemphigus diseases involve production of autoantibodies against desmogleins (DSG), which cause acantholytic intra-epidermal blisters.
The two main clinical forms of pemphigus are pemphigus vulgaris (PV), which affects the skin and mucous membranes by production of anti-DSG1 and anti-DSG3 antibodies, and pemphigus foliaceus (PF), which affects the skin by generation of anti-DSG1. [1] [2] [3] [4] [5] The production of autoantibodies against DSG is well known, but the etiopathogenesis of pemphigus still requires elucidation, and depends on interaction between genetic and environmental factors. [6] [7] [8] [9] Viral infections, like herpes simplex viruses 1 and 2 (HSV1/2), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and dengue virus (DENV), could trigger or exacerbate pemphigus. A large number of PV and PF cases are diagnosed in the northeastern region of the state of São Paulo each year. [8, 9, 14] We have investigated some viruses in patients with PV and compared them in patients with PF in this prevalent area for both PV and PF. We decided to study HSV1/2, CMV and EBV to confirm that these viruses are associated with pemphigus, mainly with PV. [15] We added DENV to our study because only a single report on PF exists, [13] and because dengue disease is endemic in our region. [16] 
| EXPERIMENTAL DESIGN
This cross-sectional study comprised a convenience sample of patients with PV and PF attended at the outpatient clinic of the university and DSG3 with ELISA kits (MBL, Japan). This study also included selected relatives (first-or second-degree ascendants or first-degree descendants) of the PV and PF patients and healthy controls (pemphigus patients' neighbours) living in the same region of the study. All the participants signed the free and informed consent. The local Research
Ethics Committee approved the project (#12248/2010).
ELISA kits (Euroimmun, Germany) helped to evaluate serum IgM and IgG antibodies against these viruses in samples from 70 and 118 patients with PV and PF, respectively, from 40 and 43 PV and PF patients' relatives, respectively, and from 42 controls (Table S1 ). Appendix S1 present the statistical analysis and more details.
| RESULTS
Seroprevalence against the viruses did not distinguish between the groups (Table S2) 
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Appendix S1 Materials and methods

Table S1
Demographic data of the studied groups and clinical information from PV and PF patients 
